BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 27977812)

  • 21. Innate immunity proteins in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
    Tsoumakidou M; Bouloukaki I; Thimaki K; Tzanakis N; Siafakas NM
    Exp Lung Res; 2010 Aug; 36(6):373-80. PubMed ID: 20653472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 8-isoprostane levels in serum and bronchoalveolar lavage in idiopathic pulmonary fibrosis and sarcoidosis.
    Malli F; Bardaka F; Tsilioni I; Karetsi E; Gourgoulianis KI; Daniil Z
    Food Chem Toxicol; 2013 Nov; 61():160-3. PubMed ID: 23702326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Renin and Soluble (Pro)renin Receptor in Patients with IPF. A Comparison with Hypersensitivity Pneumonitis.
    Eduardo M; Ivette BR; Gabriela DP; Veronica MA; Victor R
    Lung; 2019 Dec; 197(6):715-720. PubMed ID: 31616976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bronchoalveolar lavage (BAL) cells in idiopathic pulmonary fibrosis express a complex pro-inflammatory, pro-repair, angiogenic activation pattern, likely associated with macrophage iron accumulation.
    Lee J; Arisi I; Puxeddu E; Mramba LK; Amicosante M; Swaisgood CM; Pallante M; Brantly ML; Sköld CM; Saltini C
    PLoS One; 2018; 13(4):e0194803. PubMed ID: 29649237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Club Cell Protein 16 (CC16) Augmentation: A Potential Disease-modifying Approach for Chronic Obstructive Pulmonary Disease (COPD).
    Laucho-Contreras ME; Polverino F; Tesfaigzi Y; Pilon A; Celli BR; Owen CA
    Expert Opin Ther Targets; 2016 Jul; 20(7):869-83. PubMed ID: 26781659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased activated regulatory T cells proportion correlate with the severity of idiopathic pulmonary fibrosis.
    Hou Z; Ye Q; Qiu M; Hao Y; Han J; Zeng H
    Respir Res; 2017 Sep; 18(1):170. PubMed ID: 28886713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum and bronchoalveolar lavage fluid endothelin-1 concentrations as diagnostic biomarkers of canine idiopathic pulmonary fibrosis.
    Krafft E; Heikkilä HP; Jespers P; Peeters D; Day MJ; Rajamäki MM; Mc Entee K; Clercx C
    J Vet Intern Med; 2011; 25(5):990-6. PubMed ID: 21781169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [PROGNOSTIC VALUE OF BLOOD AND BRONCHOALVEOLAR LAVAGE FLUIDS BIOMARKERS FOR IDIOPATHIC PULMONARY FYBROSIS (REVIEW)].
    Yakovleva О; Klekot А; Shcherbeniuk N; Hoina-Kardasevich O
    Georgian Med News; 2019 Sep; (294):98-103. PubMed ID: 31687958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Practical management of Idiopathic Pulmonary Fibrosis.
    Kishaba T
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jul; 32(2):90-8. PubMed ID: 26278687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased alveolar soluble annexin V promotes lung inflammation and fibrosis.
    Buckley S; Shi W; Xu W; Frey MR; Moats R; Pardo A; Selman M; Warburton D
    Eur Respir J; 2015 Nov; 46(5):1417-29. PubMed ID: 26160872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis.
    Meloni F; Caporali R; Marone Bianco A; Paschetto E; Morosini M; Fietta AM; Patrizio V; Bobbio-Pallavicini F; Pozzi E; Montecucco C
    Sarcoidosis Vasc Diffuse Lung Dis; 2004 Jun; 21(2):111-8. PubMed ID: 15281432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The diagnostic value of the bronchoalveolar lavage in interstitial lung diseases.
    Efared B; Ebang-Atsame G; Rabiou S; Diarra AS; Tahiri L; Hammas N; Smahi M; Amara B; Benjelloun MC; Serraj M; Chbani L; El Fatemi H
    J Negat Results Biomed; 2017 Mar; 16(1):4. PubMed ID: 28245857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CXCL9, CXCL10, and CXCL11; biomarkers of pulmonary inflammation associated with autoimmunity in patients with collagen vascular diseases-associated interstitial lung disease and interstitial pneumonia with autoimmune features.
    Kameda M; Otsuka M; Chiba H; Kuronuma K; Hasegawa T; Takahashi H; Takahashi H
    PLoS One; 2020; 15(11):e0241719. PubMed ID: 33137121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis.
    Korthagen NM; van Moorsel CH; Barlo NP; Ruven HJ; Kruit A; Heron M; van den Bosch JM; Grutters JC
    Respir Med; 2011 Jan; 105(1):106-13. PubMed ID: 20888745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoglobulin free light chains are increased in hypersensitivity pneumonitis and idiopathic pulmonary fibrosis.
    Groot Kormelink T; Pardo A; Knipping K; Buendía-Roldán I; García-de-Alba C; Blokhuis BR; Selman M; Redegeld FA
    PLoS One; 2011; 6(9):e25392. PubMed ID: 21980441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct compartmentalization of SP-A and SP-D in the vasculature and lungs of patients with idiopathic pulmonary fibrosis.
    Nishikiori H; Chiba H; Ariki S; Kuronuma K; Otsuka M; Shiratori M; Ikeda K; Watanabe A; Kuroki Y; Takahashi H
    BMC Pulm Med; 2014 Dec; 14():196. PubMed ID: 25488319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases.
    Suga M; Iyonaga K; Ichiyasu H; Saita N; Yamasaki H; Ando M
    Eur Respir J; 1999 Aug; 14(2):376-82. PubMed ID: 10515417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of BALF concentrations of ENA-78 and IP10 in patients with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia.
    Nakayama S; Mukae H; Ishii H; Kakugawa T; Sugiyama K; Sakamoto N; Fujii T; Kadota J; Kohno S
    Respir Med; 2005 Sep; 99(9):1145-51. PubMed ID: 16085216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum Rcn3 level is a potential diagnostic biomarker for connective tissue disease-associated interstitial lung disease and reflects the severity of pulmonary function.
    Ding F; Yang L; Wang Y; Wang J; Ma Y; Jin J
    BMC Pulm Med; 2023 Feb; 23(1):68. PubMed ID: 36800954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production and activation of matrix metalloproteinase 7 (matrilysin 1) in the lungs of patients with idiopathic pulmonary fibrosis.
    Fujishima S; Shiomi T; Yamashita S; Yogo Y; Nakano Y; Inoue T; Nakamura M; Tasaka S; Hasegawa N; Aikawa N; Ishizaka A; Okada Y
    Arch Pathol Lab Med; 2010 Aug; 134(8):1136-42. PubMed ID: 20670133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.